Abstract: The present invention provides compositions including anti-tumor agents and inhibitors of Goodpasture antigen binding protein, p21, and ABCC7, and their use in treating cancer.
Type:
Grant
Filed:
July 2, 2013
Date of Patent:
June 30, 2015
Assignees:
Fibrostein, S.L., Universitat de Valencia
Inventors:
Juan Saus, Francisco Revert-Ros, Fernando Revert, Carmen Aguado-Velasco, Ernesto López-Pascual, Alejandra María Pérez-Sastre, Raúl Blasco, Héctor Pérez-Montoyo